Answers are grounded in this paper and cite their sources.
The latest European Union (EU)-level data for 2025 show divergent progress towards the five EU 2030 targets for antimicrobial consumption (AMC) and resistance. There was some EU-level progress for the target indicators for AMC. For meticillin-resistant Staphylococcus aureus, the target remained achieved, whereas third-generation cephalosporin-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae moved further from their targets. However, all resistance incidences increased compared with 2024. Sustained antimicrobial stewardship, intensified infection prevention and control, and national action plan implementation are needed.
No takes yet. Share an insight, caveat, or question.
Giske et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: